Biocryst Pharmaceuticals Inc
BCRX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000882796
No open-market purchases or sales by Biocryst Pharmaceuticals Inc insiders were filed in the last 90 days; 319 institutions reported holding it in 13F filings for Q2 2026, worth $2.61B in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Biocryst Pharmaceuticals Inc as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 233
- +29 vs. Q4 2021
- Shares held
- 127.8M
- +9.78M (+8.3%) vs. Q4 2021
- Total value
- $2.07B
- +$449.6M (+27.7%) vs. Q4 2021
- New holders
- 50
- 67 more added
- Sold out
- 21
- 71 more reduced
2 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 319 | $2.61B |
| Q1 2026 | 303 | $2.37B |
| Q4 2025 | 273 | $1.66B |
| Q3 2025 | 286 | $1.47B |
| Q2 2025 | 294 | $1.77B |
| Q1 2025 | 274 | $1.32B |
| Q4 2024 | 258 | $1.26B |
| Q3 2024 | 257 | $1.32B |
| Q2 2024 | 242 | $1.08B |
| Q1 2024 | 238 | $915.0M |
| Q4 2023 | 236 | $1.06B |
| Q3 2023 | 233 | $1.24B |
| Q2 2023 | 236 | $1.23B |
| Q1 2023 | 242 | $1.42B |
| Q4 2022 | 230 | $1.80B |
| Q3 2022 | 234 | $1.87B |
| Q2 2022 | 221 | $1.61B |
| Q1 2022 | 233 | $2.07B |
| Q4 2021 | 206 | $1.63B |
| Q3 2021 | 197 | $1.48B |
| Q2 2021 | 195 | $1.65B |
| Q1 2021 | 191 | $1.06B |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Biocryst Pharmaceuticals Inc; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 736,441 | $12.0M | 0.00% | +379,757+106.5% | Added |
| Norges Bank | 795,528 | $12.9M | 0.00% | +77,854+10.8% | Added |
| Bank of New York Mellon Corp | 892,108 | $14.5M | 0.00% | +34,176+4.0% | Added |
| Segall Bryant & Hamill, LLC | 943,792 | $15.3M | 0.15% | +943,792 | New |
| Deerfield Management Company, L.P. (Series C) | 1,012,000 | $16.5M | 0.37% | −674,140−40.0% | Reduced |
| Marshall Wace, LLP | 1,085,846 | $17.7M | 0.04% | +1,085,846 | New |
| Alkeon Capital Management LLC | 1,187,845 | $19.3M | 0.09% | +1,187,845 | New |
| Susquehanna International Group, LLP | 1,239,751 | $20.2M | 0.03% | −756,233−37.9% | Reduced |
| Goldman Sachs Group Inc | 1,273,625 | $20.7M | 0.01% | +459,965+56.5% | Added |
| Charles Schwab Investment Management Inc | 1,346,841 | $21.9M | 0.01% | +72,026+5.6% | Added |
| Sarissa Capital Management LP | 1,390,790 | $22.6M | 2.14% | −2,648,810−65.6% | Reduced |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1,665,256 | $27.1M | 0.09% | −225,904−11.9% | Reduced |
| Oracle Investment Management Inc | 1,720,733 | $28.0M | 5.63% | +50,000+3.0% | Added |
| Two Sigma Advisers, LP | 1,771,012 | $28.8M | 0.08% | −380,900−17.7% | Reduced |
| Northern Trust Corp | 1,799,898 | $29.3M | 0.01% | −61,110−3.3% | Reduced |
| Stifel Financial Corp | 1,850,342 | $30.1M | 0.04% | +8180.0% | Added |
| Avoro Capital Advisors LLC | 1,875,000 | $30.5M | 0.56% | +1,875,000 | New |
| Lord, Abbett & Co. LLC | 2,318,016 | $37.7M | 0.10% | +2,318,016 | New |
| Loomis Sayles & Co L P | 2,356,216 | $38.3M | 0.05% | +919,104+64.0% | Added |
| Nuveen Asset Management, LLC | 2,457,215 | $38.8M | 0.01% | +96,290+4.1% | Added |
| Artisan Partners Limited Partnership | 2,841,405 | $46.2M | 0.06% | +1750.0% | Added |
| Geode Capital Management, LLC | 3,281,978 | $53.4M | 0.01% | +63,502+2.0% | Added |
| Victory Capital Management Inc | 3,553,521 | $57.5M | 0.06% | +3,112,255+705.3% | Added |
| RP Management, LLC | 3,846,154 | $62.5M | 25.84% | 00.0% | Unchanged |
| Fisher Asset Management, LLC | 3,986,823 | $64.8M | 0.04% | −110,229−2.7% | Reduced |
| Pictet Asset Management SA | 5,106,903 | $83.0M | 0.09% | +51,639+1.0% | Added |
| State Street Corp | 7,462,752 | $121.3M | 0.01% | −786,277−9.5% | Reduced |
| FMR LLC | 8,414,458 | $136.8M | 0.01% | +4,518,210+116.0% | Added |
| Baker Bros. Advisors LP | 12,710,818 | $206.7M | 1.19% | 00.0% | Unchanged |
| Vanguard Group Inc | 13,207,040 | $214.7M | 0.01% | +3,794,135+40.3% | Added |
| BlackRock Inc. | 14,101,975 | $229.3M | 0.01% | −685,420−4.6% | Reduced |
| International Biotechnology Trust PLC | 57,000 | – | – | +57,000 | New |
| Sofos Investments, Inc. | 32 | – | – | +4+14.3% | Added |
| Sofinnova Investments, Inc. | 0 | $0 | 0.00% | −1,510,473−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −138,644−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −120,827−100.0% | Sold out |
| Jupiter Asset Management Ltd | 0 | $0 | 0.00% | −62,704−100.0% | Sold out |
| Gyon Technologies Capital Management, LP | 0 | $0 | 0.00% | −50,291−100.0% | Sold out |
| Spearhead Capital Advisors, LLC | 0 | $0 | 0.00% | −45,953−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −33,300−100.0% | Sold out |
| Blueshift Asset Management, LLC | 0 | $0 | 0.00% | −31,910−100.0% | Sold out |
| Sowell Financial Services LLC | 0 | $0 | 0.00% | −30,167−100.0% | Sold out |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −28,463−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −25,272−100.0% | Sold out |
| Freestone Capital Holdings, LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Ethic Inc. | 0 | $0 | 0.00% | −20,029−100.0% | Sold out |
| Nan Fung Group Holdings Ltd | 0 | $0 | 0.00% | −15,545−100.0% | Sold out |
| Regions Financial Corp | 0 | $0 | 0.00% | −15,363−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −11,042−100.0% | Sold out |
| Canada Pension Plan Investment Board | 0 | $0 | 0.00% | −215−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −150−100.0% | Sold out |
| Assetmark, Inc | 0 | $0 | 0.00% | −96−100.0% | Sold out |
| TD Capital Management LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Truvestments Capital LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| AlphaCentric Advisors LLC | – | – | – | – | Not filed |
| Carroll Financial Associates, Inc. | – | – | – | – | Not filed |